• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HALYARD - IRVINE SURGPN,400X100,HM PMP,-,EC,24; ELASTOMERIC HFR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HALYARD - IRVINE SURGPN,400X100,HM PMP,-,EC,24; ELASTOMERIC HFR Back to Search Results
Model Number E401000
Device Problem Infusion or Flow Problem (2964)
Patient Problems Headache (1880); Weakness (2145)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Udi # unknown.The sample is reported to be available for this complaint but was not returned at the time this report was submitted.The device history record for the reported lot number, 0201402443, was reviewed and documented that the lot was manufactured according to the approved manufacturing procedures, specifications, and then released by quality assurance.Per the instructions for use (ifu) there are several factors that may affect the flow rate including fill volume, temperature, viscosity of the drug solution, pump position, storage time and external pressure.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.(b)(4).
 
Event Description
Halyard received a single report that referenced two different incidences, which were associated with separate units, involving the same patient.This is the first of two reports.Refer to 2026095-2016-00125 for the second report.A report was received from (b)(6) stating the device infused within 2-hours and 2-hours and 30-minutes instead of 4-hours.The patient had headache and severe asthenia, the signs have since diminished.The room temperature was between 30°c and 35°c.The flow restrictor was taped to the patient's skin.No additional information was provided.
 
Manufacturer Narrative
The sample was returned used.The pump was refilled with 0.9% of saline using the repeater pump to the nominal value of 400ml.When refilling the pump, infusion was not observed.An empty small syringe was connected at the distal luer and negative aspiration (suction) was applied a few times, no flow was obtained.The tubing was cut a few inches distal to the blue connector (base of the pump) and infusion was observed.The tubing was bonded back together with a male and female luer using cyclohexanone.The tubing was cut a few inches distal to the filter and infusion was observed.The tubing was cut 1 inch distal to the flow control tubing and infusion was observed.Infusion was not observed at the male luer adapter.The male luer adapter was examined under a microscope magnified at 2.5x and confirms that crystalized medication was observed.The sample was placed in a heated incubator at 88 degrees for 24 hours to dislodge any of the particulates that were residing inside the component.When removed from the chamber, the remaining tubing was connected to an air source of 15 psi for approximately 1 hour to dislodge any remaining particulate matter.A small syringe with warm 0.9% of saline was connected at the proximal end of the male luer adapter and no flow was obtained.The sample was unable to be rehabilitated.The investigation summary concludes that fast flow was not observed for the returned sample.No flow was observed due to crystalized medication that impeded flow at the male luer adapter.One of assignable cause for the failure was identified as use of the product at 30-35 c, which is which is higher than the recommended temperature, 20c.It is possible that temperature contributed to this event.It is unclear that if the patient was experienced user based on the information provided.It is the responsibility of the healthcare provider to ensure patient is educated in the proper use of the system.At this time for the fast flow, the root cause is determined to be inappropriate use of the product.Halyard health has no independent knowledge of the event reported but is relaying the information that was provided by the user facility where the incident occurred.This product incident is documented in the halyard health complaint database and identified as complaint (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGPN,400X100,HM PMP,-,EC,24
Type of Device
ELASTOMERIC HFR
Manufacturer (Section D)
HALYARD - IRVINE
43 discovery
suite 100
irvine CA 92618
Manufacturer (Section G)
AVENT S. DE R.L. DE C.V.
ave noruega edificio d-1b
fraccionamiento rubio
tijuana, b.c.
Manufacturer Contact
lisa clark
5405 windward parkway
alpharetta, GA 30004
4704485444
MDR Report Key5884370
MDR Text Key53337996
Report Number2026095-2016-00123
Device Sequence Number1
Product Code MEB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PK052117
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other Health Care Professional
Device Expiration Date09/30/2016
Device Model NumberE401000
Device Catalogue Number101355400
Device Lot Number0201402443
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/25/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/28/2016
Initial Date FDA Received08/17/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/30/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/09/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age45 YR
-
-